The First Citizens Bank & Trust Co. Reduces Position in Amsurg Corp. (AMSG)

The First Citizens Bank & Trust Co. Reduces Position in Amsurg Corp. (AMSG)

First Citizens Bank & Trust Co. reduced its stake in shares of Amsurg Corp. (NASDAQ:AMSG) by 3.0% during the second quarter, Holdings Channel reports. The institutional investor owned 9,547 shares of the company’s stock after selling 291 shares during the period. First Citizens Bank & Trust Co.’s holdings in Amsurg Corp. were worth $740,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Smith Asset Management Group LP boosted its position in shares of Amsurg Corp. by 8,500.0% in the second quarter. Smith Asset Management Group LP now owns 1,720 shares of the company’s stock valued at $133,000 after buying an additional 1,700 shares in the last quarter. Invictus RG boosted its position in shares of Amsurg Corp. by 824.3% in the first quarter. Invictus RG now owns 1,904 shares of the company’s stock valued at $142,000 after buying an additional 1,698 shares in the last quarter. Checchi Capital Advisers LLC acquired a new position in shares of Amsurg Corp. during the second quarter valued at approximately $157,000. Oakbrook Investments LLC acquired a new position in shares of Amsurg Corp. during the second quarter valued at approximately $209,000. Finally, Mount Lucas Management LP boosted its position in shares of Amsurg Corp. by 10.3% in the first quarter. Mount Lucas Management LP now owns 3,483 shares of the company’s stock valued at $260,000 after buying an additional 326 shares in the last quarter. 98.43% of the stock is owned by institutional investors.

Shares of Amsurg Corp. (NASDAQ:AMSG) traded up 3.13% during midday trading on Thursday, reaching $65.47. 800,696 shares of the company traded hands. The firm has a market capitalization of $3.52 billion, a P/E ratio of 19.43 and a beta of 0.68. Amsurg Corp. has a 12 month low of $58.37 and a 12 month high of $87.29. The company has a 50 day moving average of $65.75 and a 200 day moving average of $73.19.

Amsurg Corp. (NASDAQ:AMSG) last issued its quarterly earnings results on Tuesday, August 2nd. The company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.08 by $0.02. Amsurg Corp. had a net margin of 6.53% and a return on equity of 8.20%. The firm earned $758.50 million during the quarter, compared to analyst estimates of $769.88 million. During the same quarter in the prior year, the business posted $0.97 earnings per share. Amsurg Corp.’s revenue for the quarter was up 21.5% compared to the same quarter last year. On average, equities research analysts predict that Amsurg Corp. will post $4.33 earnings per share for the current fiscal year.

Several brokerages have commented on AMSG. Zacks Investment Research raised shares of Amsurg Corp. from a “hold” rating to a “buy” rating and set a $88.00 price target for the company in a research report on Monday, July 11th. Goldman Sachs Group Inc. reissued a “buy” rating on shares of Amsurg Corp. in a research report on Friday, June 17th. Robert W. Baird reaffirmed a “buy” rating on shares of Amsurg Corp. in a research report on Thursday, June 16th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $95.00 price objective on shares of Amsurg Corp. in a research report on Thursday, July 14th. Finally, Mizuho lifted their price objective on shares of Amsurg Corp. from $90.00 to $95.00 and gave the stock a “buy” rating in a research report on Friday, June 24th. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Amsurg Corp. currently has a consensus rating of “Buy” and a consensus target price of $92.09.

In related news, insider Robert Jon Coward sold 7,500 shares of the company’s stock in a transaction that occurred on Thursday, August 18th. The shares were sold at an average price of $64.36, for a total transaction of $482,700.00. Following the completion of the transaction, the insider now owns 105,007 shares of the company’s stock, valued at $6,758,250.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 2.30% of the company’s stock.

About Amsurg Corp.

AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.

Related posts

Leave a Comment